HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC
Phase 2
Not yet recruiting
- Conditions
- Breast Cancer Stage IVHER2-low Breast CancerMolecular Imaging
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Renske Altena
- Target Recruit Count
- 70
- Registration Number
- NCT06830382
Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer
Phase 2
Terminated
- Conditions
- Early-stage Breast CancerHER2-positive Breast Cancer
- Interventions
- First Posted Date
- 2019-03-28
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Renske Altena
- Target Recruit Count
- 6
- Registration Number
- NCT03894007
- Locations
- 🇸🇪
Sahlgrenska universitetssjukhuset, Göteborg, Sweden
🇸🇪Skånes universitetssjukhus, Malmö, Sweden
🇸🇪Länssjukhuset Sundsvall, Sundsvall, Sweden
© Copyright 2025. All Rights Reserved by MedPath